Back to results
CompletedPhase 2

Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease

NCT02111122

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Department of Neurology

Zurich, Switzerland

View on ClinicalTrials.gov
Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease — TrialFind